ClinicalTrials.Veeva

Menu

Optimizing Mental Health for Young People at Clinical High Risk for Psychosis (CHR)

C

Center for Addiction and Mental Health (CAMH)

Status

Completed

Conditions

Psychosis
Psychosocial Functioning

Treatments

Behavioral: Optimal Health Program

Study type

Interventional

Funder types

Other

Identifiers

NCT05757128
063/2022

Details and patient eligibility

About

This proposal aims to adapt an evidence-based comprehensive psychosocial and mental health support program, the Optimal Health Program (OHP), to improve functioning, reduce distress, and build resiliency in youth who are at clinical risk of developing psychosis (CHR).

The main aims of the studies are 1). To adapt an existing, effective, validated psychological intervention for use in young people with CHR; 2). To evaluate the acceptability of OHP and the feasibility of conducting a clinical trial of OHP in individuals with CHR; 3). To assess the preliminary efficacy of OHP in enhancing resiliency, reducing depression and anxiety, and improving functioning in individuals with CHR in a single-arm exploratory clinical trial.

Participants will be delivered OHP intervention over 12-weeks. Measures will be completed at study entry and repeated immediately post-treatment at 12-weeks.

Enrollment

30 patients

Sex

All

Ages

16 to 29 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Be 16-29 years old
  2. Being competent and willing to consent to study participation
  3. Meets CHR criteria for a psychosis risk syndrome based on the Structured Interview for Psychosis Risk Syndromes (SIPS) either currently or at some point in the past 3 years.

Exclusion criteria

  1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis of psychotic disorder (e.g., schizophrenia spectrum disorder, mood disorder with psychotic features)
  2. Diagnosis of intellectual disability previously documented in the patient chart
  3. Severe developmental disorder
  4. Acute suicidality requiring immediate intervention

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

treatment arm
Experimental group
Description:
The single treatment arm will be administered optimal health program (OHP) intervention.
Treatment:
Behavioral: Optimal Health Program

Trial contacts and locations

1

Loading...

Central trial contact

Omair Husain, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems